Skip to main content
. 2022 Jun 24;22:572. doi: 10.1186/s12879-022-07358-7

Fig. 1.

Fig. 1

Alterations in gut fungal and bacterial diversity in patients with COVID-19 compared with healthy controls. Diversity of the gut mycobiota (AC) among patients with severe (n = 35), mild (n = 31) coronavirus disease 2019 (COVID-19) and healthy controls (n = 24). Diversity of microbiota (DF) among patients with severe (n = 40), mild (n = 38) COVID-19 and healthy controls (n = 30). A, D Shannon index. B, E Rarefaction curves. C, F Principal coordinate analysis at amplicon sequence variants (ASV) levels. *P < 0.05, ***P < 0.001